SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Human & Experimental Toxicology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Lintern, M. C
Right arrow Articles by Smith, M. E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lintern, M. C
Right arrow Articles by Smith, M. E
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Differential recovery of acetylcholinesterase in guinea pig muscle and brain regions after soman treatment

Maxine C Lintern

Department of Physiology, The Medical School, University of Birmingham, B15 2TT

Janet R Wetherell

Medical Countermeasures, CBD, Porton Down, Salisbury, Wiltshire, SP4 0JQ, UK

Margaret E Smith

Department of Physiology, The Medical School, University of Birmingham, B15 2TT

1 In brain areas of untreated guinea-pigs the highest activity of acetylcholinesterase was seen in the striatum and cerebellum, followed by the midbrain, medulla-pons and cortex, and the lowest in the hippocampus. The activity in diaphragm was sevenfold lower than in the hippocampus.

2 At 1 h after soman (27 mg/kg) administration the activity of the enzyme was dramatically reduced in all tissues studied. In muscle the three major molecular forms (A12, G4 and G1) showed a similar degree of inhibition and a similar rate of recovery and the activity had returned to normal by 7 days.

3 In the brain soman inhibited the G4 form more than the G1 form. The hippocampus, cortex and midbrain showed the greatest reductions in enzyme activity. At 7 days the activity in the cortex, medulla pons and striatum had recovered but in the hippocampus, midbrain and cerebellum it was still inhibited.

4 Thus the effects of soman administration varied in severity and time course in the different tissues studied. However the enzyme activity was still reduced in all tissues at 24 h when the overt signs of poisoning had disappeared.

Key Words: soman • anticholinesterase • acetylcholinesterase molecular forms • brain • skeletal muscle • neuromuscular junction

Human & Experimental Toxicology, Vol. 17, No. 3, 157-162 (1998)
DOI: 10.1177/096032719801700306


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
W. P. Fawcett, Y. Aracava, M. Adler, E. F. R. Pereira, and E. X. Albuquerque
Acute Toxicity of Organophosphorus Compounds in Guinea Pigs Is Sex- and Age-Dependent and Cannot Be Solely Accounted for by Acetylcholinesterase Inhibition
J. Pharmacol. Exp. Ther., February 1, 2009; 328(2): 516 - 524.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Alkondon, Y. Aracava, E. F. R. Pereira, and E. X. Albuquerque
A Single in Vivo Application of Cholinesterase Inhibitors Has Neuron Type-Specific Effects on Nicotinic Receptor Activity in Guinea Pig Hippocampus
J. Pharmacol. Exp. Ther., January 1, 2009; 328(1): 69 - 82.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
K. K. Rozman and J. Doull
The Role of Time as a Quantifiable Variable of Toxicity and the Experimental Conditions When Haber's c x t Product Can Be Observed: Implications for Therapeutics
J. Pharmacol. Exp. Ther., March 1, 2001; 296(3): 663 - 668.
[Abstract] [Full Text]



Advertisement